- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07373275
Adolescent Lifestyle Medicine Headache Study
Investigating Lifestyle Medicine Interventions for Adolescent Headache Relief
The goal of this pilot clinical trial is to assess the implementation of a 7-week Lifestyle Medicine intervention for adolescents with headache. The main question it aims to answer is:
Is it feasible to implement a Lifestyle Medicine curriculum for adolescents with headache and secondarily, does this intervention show any signal for improving headache symptoms?
Participants will be divided into two groups based on the order of their enrollment. After consent, they will be asked to complete 3 symptom surveys: PedMIDAS-6w, PHQ-A and GAD-7, in addition to a Lifestyle Survey. They will attend group medicine visits virtually, facilitated by the study team. Each week will address a different tenant of Lifestyle Medicine (such as eating or sleep) and participants will create a SMART goal to work on for the week. At the end of the seven weeks, they will repeat these symptom and lifestyle surveys. During the seven weeks, they will also keep a daily symptom diary, which will be texted to their phones through a HIPPA-compliant RedCAP database.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lifestyle Medicine is a medical specialty that emphasizes the use of group medical visits to teach and reinforce intensive, evidence-based lifestyle interventions to prevent, treat, and reverse chronic conditions such as headache. Lifestyle Medicine is built on six key pillars: restorative sleep, healthy eating, stress management, physical activity, avoiding risky substances, and positive social connection. Lifestyle modifications, including improved sleep, diet, and exercise are increasingly recommended as first-line approaches for the treatment and prevention of pediatric headache. However, these modifications are often difficult to implement consistently in adolescents due to the lack of structured, developmentally tailored programs that guide behavior change and provide ongoing support.
Study Intervention: Each group will participate in a Zoom meeting with 2-3 members of the research team for 60 minutes once a week for a 7-week program. The first week will be an introduction to the Lifestyle Medicine intervention, a conversation about confidentiality and ground rules for participation in group medical visits. Parents/guardians will be invited to participate in the introduction week if they wish. Participants will be sent a daily link to allow them to complete a headache diary to keep for the duration of the 7-week intervention. In weeks 2 through 7, the sessions will each be focused on one of the 6 lifestyle medicine pillars (restorative sleep, healthy eating, stress management, physical activity, avoiding risky substances, and positive social connection). The sessions will consist of a short presentation about the pillar and the importance of the pillar in reducing symptoms of headache. This presentation will be followed by a group discussion about how aspects of that pillar relate to the participant's experience of headache. For example, during the conversation about sleep, participants could be asked to reflect on their own sleep habits (e.g. what time they go to bed, do they fall asleep right away, is there a TV or phone in their room, do they get woken by text messages, how does fragmented sleep affect them the following day with particular emphasis on headache symptoms). At the end of each visit, each participant will make a Lifestyle Medicine SMART goal pertaining to that week's pillar. A SMART goal is a well-defined objective that is Specific, Measurable, Achievable, Realistic and Time-bound. This goal setting will be done in small breakout groups with study team members; during the session about substance use, goal setting will be done one-on-one. Participants will be asked to collect data during the following week on how successful they were in achieving their SMART goal. They will also be asked to keep a record of their headache symptoms in the headache diary. Study team members will record the goal setting in the electronic medical record (EPIC) and keep study notes about the sessions weekly through RedCAP, which include a feasibility checklist as well as narrative data re: the Proctor Model (Acceptability, Appropriateness, Costs, Feasibility, Fidelity, Penetration, Sustainability).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maine
-
Scarborough, Maine, United States, 04074
- MaineHealth Pediatric Neurology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 14-18 years old
- Frequent episodic migraine headaches with our without aura (>4 months)
- Patient at MaineHealth Pediatric Neurology or MaineHealth Pediatrics Portland
- Current High School Enrollment
- English Speaking
Exclusion Criteria:
- Age <14 year or >18 years
- Diagnosis of eating disorder or Autism Spectrum Disorder
- PHQ-A scores of 20 or higher
- Intractable/daily headache
- Headache secondary to specific medical or neurological conditions (e.g. brain tumor, infection, trauma)
- Increase in prophylactic headache medication 6 weeks prior to the onset of intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The Lifestyle Medicine Intervention Arm
All participants will receive the Lifestyle Medicine Group Medical Visit intervention, whether they are in group 1 or group 2.
|
Participants will attend a virtual, one-hour weekly lifestyle medicine group session with their peers for 7 weeks.
Each session will address one pillar of Lifestyle Medicine: restorative sleep, healthy eating, stress management, physical activity, avoiding risky substances, and positive social connection.
During each session, study team members will provide a short presentation of key components of that lifestyle intervention and meet with participants in small groups to discuss goals related to that pillar (i.e.
eat 2 more vegetables a day for five days).
During the course of these 7 weeks, participants will also keep a virtual daily headache journal; a link to this journal will be sent through an automated text with a HIPPA-compliant REDCap database.
This will be sent daily at 5 pm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attendance
Time Frame: From enrollment to end of treatment at 3 months
|
For this outcome, we will track how often participants attend the group meetings.
There will be seven group meetings to attend, one per week.
Attendance will be tracked at each meeting by group facilitators.
We will calculate the overall percentage of attendance for each participant over the seven weeks and report the mean percentage.
We anticipate >75% attendance to be successful.
|
From enrollment to end of treatment at 3 months
|
|
Headache Diary Completion
Time Frame: From enrollment to end of treatment at 3 months
|
For this outcome, we will track how often participants attend the group meetings.
There will be seven group meetings to attend, one per week.
Attendance will be tracked at each meeting by group facilitators.
We will calculate the overall percentage of attendance for each participant over the seven weeks and report the mean percentage.
We anticipate >75% attendance to be successful.
|
From enrollment to end of treatment at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive Lifestyle Changes
Time Frame: From enrollment to end of treatment at three months
|
For this outcome, participants will be taking the survey Pediatric Lifestyle Medicine Assessment for Headache.
This survey assesses nutrition and sleep.
They will take this survey at their intake appointment and 7 weeks following the conclusion group medical visit sessions.
For sleep, we anticipate measuring success through an increase in one hour or more of sleep nightly over the course of three surveys; we anticipate measuring nutrition through a decrease in skipped breakfasts by 25%.
|
From enrollment to end of treatment at three months
|
|
Headache Symptoms
Time Frame: From enrollment through 3 months.
|
For this outcome, participants will be filling out a daily headache diary, texted automatically through RedCAP.
The first question asks if they had a headache in the last 24 hours, yes or no.
To calculate the presence of headache in participants, we will [Anya?
How do we get our number and what does the number mean?]
A logistic mixed effects regression model will be used with a fixed effect for day and a random effect for participant to determine if the odds of headache decreases over time.
|
From enrollment through 3 months.
|
|
Headache Severity
Time Frame: From enrollment through 3 months.
|
or this outcome, participants will be filling out a daily headache diary, texted automatically through RedCAP.
If participants answer yes to headache presence in the first question, they will be asked a series of other questions.
One question asks about headache severity, using a Likert scale.
To analyze this, we will assign absence of headache as 0, and assess improvement in severity over time using a linear mixed effects model with a fixed effect for day and a random effect for participant.
|
From enrollment through 3 months.
|
|
Headache Symptom Reduction
Time Frame: From enrollment through 3 months.
|
For this outcome, participants will be taking a commonly, clinically-used headache symptom survey, the Peds-MIDAS.
The Peds-MIDAS will be adapted to be taken at 6 week intervals (Peds-MIDAS6w).
Participants will take the Peds-MIDAS6w at their intake session, at their final group session, and 7 weeks following the completion of the study.
They will score from 0-50, with 50 being the most severe.
To assess improvement over time, we will use a linear mixed effects regression model with a random effect for participant, with success measured by a decrease in patient score by 10%.
|
From enrollment through 3 months.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jennifer Dubail, M.D., MaineHealth
- Principal Investigator: Helis Jason, M.D., MaineHealth
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- mainehealth
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Headache, Migraine
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingMigraine | Migraine Headache | Migraine Without Aura | Migraine with Aura | Chronic Migraine, Headache | Episodic Migraine | Chronic Migraine Headache | Headache (Migraine) | Episodic Migraine HeadacheSpain
-
University Medical Centre LjubljanaActive, not recruitingMigraine | Migraine Headache | Migraine Headache, With or Without Aura | Migraine in AdultsSlovenia
-
Ain Shams UniversityRecruitingMigraine | Migraine Headache | Migraine, Acute | Migraine Headache, With or Without Aura | Migraine DiseaseEgypt
-
The Cleveland ClinicWithdrawnMigraine | Migraine Disorders | Headache Disorders, Primary | Migraine Headache | Migraine Without Aura | Migraine With Aura | Headache, MigraineUnited States
-
Johns Hopkins UniversityMedtronicRecruitingMigraine | Chronic Migraine Headache | Refractory MigraineUnited States
-
Fundación de Investigación Biomédica - Hospital...Hospital Universitario La Fe; Hospital Vall d'Hebron; Hospital Universitario... and other collaboratorsRecruitingMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraSpain
-
Miracle Wellness LLCNot yet recruitingMigraine | Migraine Headache | Menstrual Migraine | Menstrual Migraine (MM) Headaches | Migraine Disorder | Migraine in Adults | Migraine Disease | Migraine DisabilityUnited States
-
Ariston Pharmaceuticals, Inc.UnknownMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraFinland, Netherlands, United Kingdom
-
TheranicaActive, not recruitingMigraine | Chronic Migraine HeadacheUnited States
-
Danish Headache CenterCompletedHeadache, Migraine | AuraDenmark
Clinical Trials on Lifestyle Medicine Group Medical Visits
-
Boston Medical CenterCompletedDepression | Chronic PainUnited States
-
Université de SherbrookeRecruiting
-
University of Southern CaliforniaTerminatedOveractive Bladder | Urge Incontinence | Urinary UrgencyUnited States
-
University of ManitobaRecruitingMental Health Care | Pilot Study | Anxiety and DepressionCanada
-
University of British ColumbiaYMCA; Vancouver Foundation; Mood Disorders Association of BCUnknownMajor Depressive Disorder | Bipolar, DepressionCanada
-
VA Office of Research and DevelopmentCompleted
-
Chinese University of Hong KongRecruiting
-
Brigham and Women's HospitalRecruitingMusculoskeletal Pain | Chronic PainUnited States
-
Boston Medical CenterBoston University; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompleted
-
University of California, San FranciscoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingChronic PainUnited States